跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
信乐妥 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Lefamulin Acetate Concentrated Solution for Injection
Approved
化学药品
Lefamulin Acetate Concentrated Solution for Injection
Nabriva Therapeutics Ireland DAC
🇨🇳 National Medical Products Administration
Approval Date
Nov 14, 2023
Approval ID
8VIZm4OuDfA
Company
Nabriva Therapeutics Ireland DAC
Type
化学药品
Approval Details
Approval Id
8VIZm4OuDfA
Approval Number
国药准字HJ20230128
Generic Name
醋酸来法莫林注射用浓溶液
Generic Name En
Lefamulin Acetate Concentrated Solution for Injection
Trade Name
信乐妥
Drug Type
化学药品
Dosage Form
注射剂
Strength
15ml：0.15g（按C₂₈H₄₅NO₅S计）
Reg Date
2023-11-14
Expired Date
2028-11-13
Company Name
Nabriva Therapeutics Ireland DAC
Company Detail Path
/organization/nabriva-therapeutics-ireland-dac
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Nov 14, 2023
Approval ID
8VIZm4OuDfA
Type
化学药品
Back to NMPA Approvals
